Skip to content

Clinical trials

Phase 2 Muscle Weakness trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscle Weakness Phase: Phase 2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20042
20102
20121
20141
20171
20181
20191
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc1
Axcella Health, Inc1
Baylor College of Medicine1
Biophytis1
Eli Lilly and Company1
GlaxoSmithKline1
Jeffrey A. Cohen, MD1
Mahidol University1
Montreal Heart Institute1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscle Weakness18
COVID-192
Dermatomyositis2
Fatigue2
Inflammation2
Mitochondrial Diseases2
Muscular Atrophy2
Pain2
Polymyositis2
Pulmonary Disease, Chronic Obstructive2

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.